PATENT CLAIM ANALYSIS

Application Number: 15999517
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "457000"]

Abstract:
A composition for injection into a host is provided according to the embodiments of the present application. The composition consists of microparticles consisting essentially of an opioid antagonist and a polymeric binder selected from the group consisting of poly(glycolic acid), poly-d,l-lactic acid, poly-l-lactic acid, copolymers of the foregoing, poly(aliphatic carboxylic acids), copolyoxalates, polycaprolactone, polydioxanone, poly(ortho carbonates), poly(acetals), poly(lactic acid-caprolactone), polyorthoesters, poly(glycolic acid-caprolactone), polyanhydrides, and polyphosphazines; an injection vehicle, wherein said injection vehicle consists of water, a viscosity enhancing agent, a wetting agent, and a tonicity adjusting agent; and a steroidal anti-inflammatory agent.

Claim (Index 26):
A method for treating a patient having an opioid dependency comprising parenterally administering to the patient a therapeutically effective amount of the composition of  claim 18  or  19  once per month to treat the opioid dependency.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 96.0
- Lexical Diversity: 1.94203
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13445716', '12101943', '14390322', '10159559', '10324062']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7082957511407739
- 35 USC 102 Novelty (BERT): 0.5064505717290798
- Combined Prediction Score: 0.6881112331996045
- Mean Citation Score: 252.67313
- Max Citation Score: 256.72427000000005
- Similarity Product: 169.28251112437255

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test